Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls

NeuroImage

Volumn 56, Issue 4, 2011, Pages 2283-2291

  Papagni, Sergio Alessandro ^a,b   Mechelli, Andrea ^a   Prata, Diana P ^a   Kambeitz, Joseph ^a   Fu, Cynthia H Y ^a   Picchioni, Marco ^a   Walshe, Muriel ^a   Toulopoulou, Timothea ^a   Bramon, Elvira ^a   Murray, Robin M ^a   Collier, David A ^a   Bellomo, Antonello ^b   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Bipolar disorder; DAAO; FMRI; Imaging genetics; Schizophrenia; Verbal fluency

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; BRAIN FUNCTION; BRAIN MAPPING; CONTROLLED STUDY; DAAO GENE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; POSTERIOR CINGULATE; PRECUNEUS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VERBALIZATION;

ADULT; BIPOLAR DISORDER; BRAIN MAPPING; D-AMINO-ACID OXIDASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NEURAL PATHWAYS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 79957446299     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.03.037     Document Type: Article

References (75)

1. Addington A.M., Gornick M.C., Shaw P., Seal J., Gogtay N., Greenstein D., et al. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol. Psychiatry 2007, 12(2):195-205.
2. Ammons R.B., Ammons C.H. The Quick Test 1962, Psychological Test Specialists, Missoula, MT.
3. Bass N.J.., Datta S.R., McQuillin A., Puri V., Choudhury K., Thirumalai S., Lawrence J., Quested D., Pimm J., Curtis D., Gurling H.M. Evidence for the association of the DAOA (G72) gene with schizophrenia and bipolar disorder but not for the association of the DAO gene with schizophrenia. Behav. Brain Funct. 2009, 5:28. Jul 8.
4. Berrettini W. Bipolar disorder and schizophrenia: not so distant relatives?. World Psychiatry 2003, 2(2):68-72. Jun.
5. Binder J.R., Frost J.A., Hammeke T.A., Bellgowan P.S., Rao S.M., Cox R.W. Conceptual processing during the conscious resting state. A functional MRI study. J. Cogn. Neurosci. 1999, 11(1):80-95.
6. Boks M.P., Rietkerk T., van de Beek M.H., Sommer I.E., de Koning T.J., Kahn R.S. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur. Neuropsychopharmacol. 2007, 17(9):567-572. Review.
7. Cardno A.G., Rijsdijk F.V., Sham P.C., Murray R.M., McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am. J. Psychiatry 2002, 159(4):539-545. Apr.
8. Caspi A., Moffitt T.E. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat. Rev. Neurosci. 2006, 7(7):583-590. Jul, Review.
9. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., Bougueleret L., Barry C., Tanaka H., La Rosa P., Puech A., Tahri N., Cohen-Akenine A., Delabrosse S., Lissarrague S., Picard F.P., Maurice K., Essioux L., Millasseau P., Grel P., Debailleul V., Simon A.M., Caterina D., Dufaure I., Malekzadeh K., Belova M., Luan J.J., Bouillot M., Sambucy J.L., Primas G., Saumier M., Boubkiri N., Martin-Saumier S., Nasroune M., Peixoto H., Delaye A., Pinchot V., Bastucci M., Guillou S., Chevillon M., Sainz-Fuertes R., Meguenni S., Aurich-Costa J., Cherif D., Gimalac A., Van Duijn C., Gauvreau D., Ouellette G., Fortier I., Raelson J., Sherbatich T., Riazanskaia N., Rogaev E., Raeymaekers P., Aerssens J., Konings F., Luyten W., Macciardi F., Sham P.C., Straub R.E., Weinberger D.R., Cohen N., Cohen D. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl Acad. Sci. U. S. A. 2002, 99(21):13675-13680. Oct 15, Epub 2002 Oct 3.
10. Corvin A., McGhee K.A., Murphy K., Donohoe G., Nangle J.M., Schwaiger S., Kenny N., Clarke S., Meagher D., Quinn J., Scully P., Baldwin P., Browne D., Walsh C., Waddington J.L., Morris D.W., Gill M. Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(7):949-953. Oct 5.
11. Coyle J.T., Tsai G., Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. N. Y. Acad. Sci. 2003, 1003:318-327. Nov.
12. Craddock N., O'Donovan M.C., Owen M.J. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 2006, 32(1):9-16. Jan, Epub 2005 Nov 30, Review.
13. Craddock N., O'Donovan M.C., Owen M.J. Phenotypic and genetic complexity of psychosis. Invited commentary on... Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiatry 2007, 190:200-203. Mar.
14. Curtis V.A., Dixon T.A., Morris R.G., Bullmore E.T., Brammer M.J., Williams S.C., Sharma T., Murray R.M., McGuire P.K. Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J. Affect. Disord. 2001, 66(2-3):111-121. Oct.
15. Daban C., Martinez-Aran A., Torrent C., Tabarés-Seisdedos R., Balanzá-Martínez V., Salazar-Fraile J., Selva-Vera G., Vieta E. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother. Psychosom. 2006, 75(2):72-84.
16. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004, 61(5):450-458. May.
17. Fallin M.D., Lasseter V.K., Avramopoulos D., Nicodemus K.K., Wolyniec P.S., McGrath J.A., Steel G., Nestadt G., Liang K.Y., Huganir R.L., Valle D., Pulver A.E. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am. J. Hum. Genet. 2005, 77(6):918-936. Dec, Epub 2005 Oct 28.
18. Freeman B., Smith N., Curtis C., Huckett L., Mill J., Craig I.W. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav. Genet. 2003, 33(1):67-72.
19. Friston K.J. Introduction: experimental design and statistical parametric mapping. Human Brain Function 2003, 599-632. Academic Press. R.S.J. Frackowiak, K.J. Friston, C. Frith, R. Dolan, K.J. Friston, C.J. Price, S. Zeki, J. Ashburner, W.D. Penny (Eds.).
20. Friston K.J., Buechel C., Fink G.R., Morris J., Rolls E., Dolan R.J. Psychophysiological and modulatory interactions in neuroimaging. Neuroimage 1997, 6(3):218-229. Oct.
21. Frith C.D., Leary J., Cahill C., Johnstone E.C. Performance on psychological tests. Demographic and clinical correlates of the results of these tests. Br. J. Psychiatry Suppl. 1991, (13):26-29. Oct, 44-6.
22. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., Bottlender R., Schüle C., Zwanzger P., Engel R.R., Rupprecht R., Bondy B., Reiser M., Möller H.J. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch. Gen. Psychiatry 2004, 61(2):177-183. Feb.
23. Fu C.H., Morgan K., Suckling J., Williams S.C., Andrew C., Vythelingum G.N. A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demand. NeuroImage 2002, 17(2):871-879.
24. Fu C.H., Suckling J., Williams S.C., Andrew C.M., Vythelingum G.N., McGuire P.K. Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am. J. Psychiatry 2005, 162(3):485-494. Mar.
25. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., Coppola R., Egan M.F., Weinberger D.R. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 2006, 31(9):2022-2032. Sep, Epub 2006 Mar 22.
26. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 2003, 23(15):6315-6326.
27. Hashimoto K., Engberg G., Shimizu E., Nordin C., Lindström L.H., Iyo M. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(5):767-769.
28. Hashimoto K., Fujita Y., Horio M., Kunitachi S., Iyo M., Ferraris D., Tsukamoto T. Co-administration of a d-amino acid oxidase inhibitor potentiates the efficacy of d-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol. Psychiatry 2009, 65(12):1103-1106. Jun 15, Epub 2009 Feb 12.
29. Heresco-Levy U. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia. Expert Opin. Emerg. Drugs 2005, 10(4):827-844. Review.
30. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148(10):1301-1308. Oct, Review.
31. Kapoor R., Lim K.S., Cheng A., Garrick T., Kapoor V. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). Brain Res. 2006, 1106(1):205-210. Aug 23, Epub 2006 Jul 7.
32. Kim D.I., Manoach D.S., Mathalon D.H., Turner J.A., Mannell M., Brown G.G., Ford J.M., Gollub R.L., White T., Wible C., Belger A., Bockholt H.J., Clark V.P., Lauriello J., O'Leary D., Mueller B.A., Lim K.O., Andreasen N., Potkin S.G., Calhoun V.D. Dysregulation of working memory and default-mode networks in schizophrenia using independent component analysis, an fBIRN and MCIC study. Hum. Brain Mapp. 2009, 30(11):3795-3811. Nov.
33. Krabbendam L., Arts B., van Os J., Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr. Res. 2005, 80(2-3):137-149.
34. Kravariti E., Dixon T., Frith C., Murray R., McGuire P. Association of symptoms and executive function in schizophrenia and bipolar disorder. Schizophr. Res. 2005, 74(2-3):221-231. May 1.
35. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lönnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoëga T., Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 2003, 73(1):34-48. Jul, Epub 2003 Jun 11.
36. Li D., He L. G72/G30 genes and schizophrenia: a systematic meta-analysis of association studies. Genetics 2007, 175(2):917-922. Feb, Epub 2006 Dec 18.
37. Li X., Ketter T.A., Frye M.A. Synaptic, intracellular and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?. J. Affect. Disord. 2002, 69(1-3):1-14. May, Review.
38. Liu X., He G., Wang X., Chen Q., Qian X., Lin W., Li D., Gu N., Feng G., He L. Association of DAAO with schizophrenia in the Chinese population. Neurosci. Lett. 2004, 369(3):228-233. Oct 21.
39. Liu Y.L., Fann C.S., Liu C.M., Chang C.C., Wu J.Y., Hung S.I., Liu S.K., Hsieh M.H., Hwang T.J., Chan H.Y., Chen J.J., Faraone S.V., Tsuang M.T., Chen W.J., Hwu H.G. No association of G72 and d-amino acid oxidase genes with schizophrenia. Schizophr. Res. 2006, 87(1-3):15-20. Oct, Epub 2006 Jul 13.
40. Madeira C., Freitas M.E., Vargas-Lopes C., Wolosker H., Panizzutti R. Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr. Res. 2008, 101(1-3):76-83. Apr, Epub 2008 Apr 2.
41. McGuire P.K., Paulesu E., Frackowiak R.S., Frith C.D. Brain regions active during stimulus independent thought. Neuroreport 1996, 7(13):2095-2099. Sep 2.
42. McKiernan K.A., Kaufman J.N., Kucera-Thompson J., Binder J.R. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci. 2003, 15(3):394-408. Apr 1.
43. McKiernan K.A., D'Angelo B.R., Kaufman J.N., Binder J.R. Interrupting the "stream of consciousness": an fMRI investigation. Neuroimage 2006, 29(4):1185-1191. Feb 15, Epub 2005 Nov 2.
44. Mechelli A., Prata D.P., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Demjaha A., Kravariti E., Toulopoulou T., Murray R., Collier D.A., McGuire P.K. The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage 2008, 42(2):817-826. Aug 15, Epub 2008 May 27.
45. Michael N., Erfurth A., Ohrmann P., Gössling M., Arolt V., Heindel W., Pfleiderer B. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology (Berl.) 2003, 168(3):344-346. Jul, Epub 2003 Apr 9.
46. Moskvina V., O'Donovan M.C. Detailed analysis of the relative power of direct and indirect association studies and the implications for their interpretation. Hum. Hered. 2007, 64(1):63-73. Epub 2007 Apr 27.
47. Ohnuma T., Shibata N., Maeshima H., Baba H., Hatano T., Hanzawa R., Arai H. Association analysis of glycine- and serine-related genes in a Japanese population of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(3):511-518. Apr 30, Epub 2009 Feb 14.
48. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52(12):998-1007.
49. Owen M. Imaging genetics in psychiatry: disease path or garden path?. Schizophr. Res. 2010, 117:123.
50. Owen M.J., Craddock N., Jablensky A. The genetic deconstruction of psychosis. Schizophr. Bull. 2007, 33(4):905-911. Jul, Epub 2007 Jun 5.
51. Park N., Juo S.H., Cheng R., Liu J., Loth J.E., Lilliston B., Nee J., Grunn A., Kanyas K., Lerer B., Endicott J., Gilliam T.C., Baron M. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia. Mol. Psychiatry 2004, 9(12):1091-1099. Dec.
52. Prata D., Breen G., Osborne S., Munro J., St Clair D., Collier D. Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B(6):914-917. Sep 5.
53. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Kravariti E., Toulopoulou T., Miorelli A., Murray R., Collier D.A., McGuire P.K. Effect of disrupted-in-schizophrenia-1 on pre-frontal cortical function. Mol. Psychiatry 2008, 13(10):915-917. Oct, 909.
54. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Toulopoulou T., Bramon E., Walshe M., Murray R.M., Collier D.A., McGuire P. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc. Natl Acad. Sci. U. S. A. 2009, 106(32):13600-13605. Aug 11, Epub 2009 Jul 28.
55. Prata D.P., Mechelli A., Fu C.H., Picchioni M., Kane F., Kalidindi S., McDonald C., Howes O., Kravariti E., Demjaha A., Toulopoulou T., Diforti M., Murray R.M., Collier D.A., McGuire P.K. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol. Psychiatry 2009, 65(6):473-480. Mar 15, Epub 2008 Dec 3.
56. Schumacher J., Jamra R.A., Freudenberg J., Becker T., Ohlraun S., Otte A.C., Tullius M., Kovalenko S., Bogaert A.V., Maier W., Rietschel M., Propping P., Nöthen M.M., Cichon S. Examination of G72 and d-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol. Psychiatry 2004, 9(2):203-207. Feb.
57. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger J.I., Craddock N., DePaulo J.R., Baron M., Gershon E.S., Ekholm J., Cichon S., Turecki G., Claes S., Kelsoe J.R., Schofield P.R., Badenhop R.F., Morissette J., Coon H., Blackwood D., McInnes L.A., Foroud T., Edenberg H.J., Reich T., Rice J.P., Goate A., McInnis M.G., McMahon F.J., Badner J.A., Goldin L.R., Bennett P., Willour V.L., Zandi P.P., Liu J., Gilliam C., Juo S.H., Berrettini W.H., Yoshikawa T., Peltonen L., Lönnqvist J., Nöthen M.M., Schumacher J., Windemuth C., Rietschel M., Propping P., Maier W., Alda M., Grof P., Rouleau G.A., Del-Favero J., Van Broeckhoven C., Mendlewicz J., Adolfsson R., Spence M.A., Luebbert H., Adams L.J., Donald J.A., Mitchell P.B., Barden N., Shink E., Byerley W., Muir W., Visscher P.M., Macgregor S., Gurling H., Kalsi G., McQuillin A., Escamilla M.A., Reus V.I., Leon P., Freimer N.B., Ewald H., Kruse T.A., Mors O., Radhakrishna U., Blouin J.L., Antonarakis S.E., Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am. J. Hum. Genet. 2003, 73(1):49-62. Jul, Epub 2003 Jun 11.
58. Shinkai T., De Luca V., Hwang R., Müller D.J., Lanktree M., Zai G., Shaikh S., Wong G., Sicard T., Potapova N., Trakalo J., King N., Matsumoto C., Hori H., Wong A.H., Ohmori O., Macciardi F., Nakamura J., Kennedy J.L. Association analyses of the DAOA/G30 and d-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia. Neuromolecular Med. 2007, 9(2):169-177.
59. Shulman G.L., Fiez J.A., Corbetta M., Buckner R.L., Miezin F.M., Raichle M.E., Petersen S.E. Common blood flow changes across visual tasks. 2. Decreases in cerebral cortex. J. Cogn. Neurosci. 1997, 5:648-663.
60. Sklar P. Linkage analysis in psychiatric disorders: the emerging picture. Annu. Rev. Genomics Hum. Genet. 2002, 3:371-413.
61. Stefanis N.C., Trikalinos T.A., Avramopoulos D., Smyrnis N., Evdokimidis I., Ntzani E.E., Ioannidis J.P., Stefanis C.N. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol. Psychiatry 2007, 62(7):784-792. Oct 1.
62. Stone J.M., Day F., Tsagaraki H., Valli I., McLean M.A., Lythgoe D.J., O'Gorman R.L., Barker G.J., McGuire P.K. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol. Psychiatry 2009, 66(6):533-539.
63. Tanii Y., Nishikawa T., Hashimoto A., Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J. Pharmacol. Exp. Ther. 1994, 269(3):1040-1048.
64. Tuominen H.J., Tiihonen J., Wahlbeck K. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 2005, 72(2-3):225-234. Review.
65. Vanhaudenhuyse A., Noirhomme Q., Tshibanda L.J., Bruno M.A., Boveroux P., Schnakers C., Soddu A., Perlbarg V., Ledoux D., Brichant J.F., Moonen G., Maquet P., Greicius M.D., Laureys S., Boly M. Default network connectivity reflects the level of consciousness in non-communicative brain-damaged patients. Brain 2010, 133(Pt 1):161-171. Jan.
66. Verrall L., Walker M., Rawlings N., Benzel I., Kew J.N., Harrison P.J., Burnet P.W. d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur. J. Neurosci. 2007, 26(6):1657-1669.
67. Verrall L., Burnet P.W., Betts J.F., Harrison P.J. The neurobiology of d-amino acid oxidase and its involvement in schizophrenia. Mol. Psychiatry 2010, 15(2):122-137.
68. Wechsler D. Manual for the Wechsler Intelligence Scale - Revised 1981, Psychological Corporation.
69. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition Manual 1997, Psychological Corporation.
70. Wechsler D. Wechsler Abbreviated Scale of Intelligence 1999, Psychological Corporation.
71. Weinberger D. On the matter of neuroimaging in the context of schizophrenia genetics. Schizophr. Res. 2010, 117:109-110.
72. Whalley H.C., Simonotto E., Marshall I., Owens D.G., Goddard N.H., Johnstone E.C., Lawrie S.M. Functional disconnectivity in subjects at high genetic risk of schizophrenia. Brain 2005, 128(Pt 9):2097-2108.
73. Whitfield-Gabrieli S., Thermenos H.W., Milanovic S., Tsuang M.T., Faraone S.V., McCarley R.W., Shenton M.E., Green A.I., Nieto-Castanon A., LaViolette P., Wojcik J., Gabrieli J.D., Seidman L.J. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc. Natl Acad. Sci. U. S. A. 2009, 106(4):1279-1284. Epub 2009 Jan 21.
74. Wood L.S., Pickering E.H., Dechairo B.M. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol. Psychiatry 2007, 61(10):1195-1199.
75. Yamada K., Ohnishi T., Hashimoto K., Ohba H., Iwayama-Shigeno Y., Toyoshima M., Okuno A., Takao H., Toyota T., Minabe Y., Nakamura K., Shimizu E., Itokawa M., Mori N., Iyo M., Yoshikawa T. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and d-serine levels. Biol. Psychiatry 2005, 57(12):1493-1503.